Literature DB >> 1665061

Bovine brain microsomal CDP-diacylglycerol synthetase: solubilization and properties.

C H Lin1, J Lin, K P Strickland.   

Abstract

CDP-diacylglycerol(DAG) synthetase (EC 2.7.7.41) has been solubilized from bovine brain microsomes by the detergent CHAPS (3-[(3-cholamidopropyl) dimethylammonio] -1-propanesulfonate). Optimal solubilization with 1.5% CHAPS yielded 55-60% of the synthetase activity. The effect of CHAPS on the enzyme was biphasic inhibiting at 0.3% and giving maximal activity at 0.5% (the concentration used for all assays). The solubilized, but not the microsomal enzyme is activated by phosphatidylcholine (PC) and strongly inhibited by cardiolipin and lysoPC. Strong inhibition by N-ethylmaleimide, 5,5'-dithio-bis (2-nitrobenzoic acid) and p-chloromercuribenzoate supported a sulfhydryl requirement for the enzyme. Phosphatidic acid (PA) from egg lecithin and 1-stearoyl,2-arachidonoyl PA were preferred substrates for the microsomal synthetase. Solubilized synthetase showed selectivity for the latter PA which is consistent with this enzyme functioning to help form the preponderant 1-stearoyl,2-arachidonoyl species of phosphatidylinositol. Further attempts to purify the synthetase were unsuccessful. All findings suggested the enzyme exists as an unstable complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665061

Source DB:  PubMed          Journal:  Biochem Int        ISSN: 0158-5231


  3 in total

1.  On the mechanism of the phospholipase C-mediated attenuation of cardiolipin biosynthesis in H9c2 cardiac myoblast cells.

Authors:  F Y Xu; S L Kelly; W A Taylor; G M Hatch
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

2.  Dramatic differences in the roles in lipid metabolism of two isoforms of diacylglycerol kinase.

Authors:  Stephen B Milne; Pavlina T Ivanova; Michelle D Armstrong; David S Myers; Jovana Lubarda; Yulia V Shulga; Matthew K Topham; H Alex Brown; Richard M Epand
Journal:  Biochemistry       Date:  2008-08-15       Impact factor: 3.162

3.  Hepatoprotectant ursodeoxycholyl lysophosphatidylethanolamide increasing phosphatidylcholine levels as a potential therapy of acute liver injury.

Authors:  Walee Chamulitrat; Wujuan Zhang; Weihong Xu; Anita Pathil; Kenneth Setchell; Wolfgang Stremmel
Journal:  Front Physiol       Date:  2012-02-20       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.